These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9696930)

  • 21. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
    Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
    Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
    Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Genetic polymorphisms of NQO1, GSTT1, GSTM1 and susceptibility to chronic benzene poisoning].
    Chen Y; Li GL; Ji ZY; Xu JN; Wu CL
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2005 Feb; 23(1):1-5. PubMed ID: 15748501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphism of drug-metabolizing enzymes in relation to individual susceptibility to industrial chemicals.
    Nakajima T; Aoyama T
    Ind Health; 2000 Apr; 38(2):143-52. PubMed ID: 10812837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility.
    Wikman H; Thiel S; Jäger B; Schmezer P; Spiegelhalder B; Edler L; Dienemann H; Kayser K; Schulz V; Drings P; Bartsch H; Risch A
    Pharmacogenetics; 2001 Mar; 11(2):157-68. PubMed ID: 11266080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-Acetyltransferase-2, glutathione S-transferase M1 and T1 genetic polymorphisms, cigarette smoking and hepatocellular carcinoma: a case-control study.
    Gelatti U; Covolo L; Talamini R; Tagger A; Barbone F; Martelli C; Cremaschini F; Franceschi S; Ribero ML; Garte S; Nardi G; Donadon V; Donato F
    Int J Cancer; 2005 Jun; 115(2):301-6. PubMed ID: 15688397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 mutations in bladder cancer: evidence for exogenous versus endogenous risk factors.
    Schroeder JC; Conway K; Li Y; Mistry K; Bell DA; Taylor JA
    Cancer Res; 2003 Nov; 63(21):7530-8. PubMed ID: 14612556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer.
    Li D; Jiao L; Li Y; Doll MA; Hein DW; Bondy ML; Evans DB; Wolff RA; Lenzi R; Pisters PW; Abbruzzese JL; Hassan MM
    Carcinogenesis; 2006 Jan; 27(1):103-11. PubMed ID: 15987714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H:quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury.
    Huang YS; Su WJ; Huang YH; Chen CY; Chang FY; Lin HC; Lee SD
    J Hepatol; 2007 Jul; 47(1):128-34. PubMed ID: 17400324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis.
    Hein DW
    Mutat Res; 2002 Sep; 506-507():65-77. PubMed ID: 12351146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NAD(P)H: Quinone oxidoreductase 1, glutathione S-transferase M1, environmental tobacco smoke exposure, and childhood asthma.
    Li YF; Tseng PJ; Lin CC; Hung CL; Lin SC; Su WC; Huang YL; Sung FC; Tai CK
    Mutat Res; 2009 Aug; 678(1):53-8. PubMed ID: 19591959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer.
    Olshan AF; Weissler MC; Watson MA; Bell DA
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):185-91. PubMed ID: 10698480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased levels of NAD(P)H: quinone oxidoreductase 1 (NQO1) in pancreatic tissues from smokers and pancreatic adenocarcinomas: A potential biomarker of early damage in the pancreas.
    Lyn-Cook BD; Yan-Sanders Y; Moore S; Taylor S; Word B; Hammons GJ
    Cell Biol Toxicol; 2006 Mar; 22(2):73-80. PubMed ID: 16532285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of GSTT1, GSTM1 and NQO1 (609C>T) in Filipino children with ALL (acute lymphoblastic leukaemia).
    Rimando MG; Chua MN; Yuson Ed; de Castro-Bernas G; Okamoto T
    Biosci Rep; 2008 Jun; 28(3):117-24. PubMed ID: 18444911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma.
    Hirvonen A; Pelin K; Tammilehto L; Karjalainen A; Mattson K; Linnainmaa K
    Cancer Res; 1995 Jul; 55(14):2981-3. PubMed ID: 7606714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic polymorphisms of GSTT1, GSTM1, and NQO1 genes and diabetes mellitus risk in Chinese population.
    Wang G; Zhang L; Li Q
    Biochem Biophys Res Commun; 2006 Mar; 341(2):310-3. PubMed ID: 16413497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma.
    Morton LM; Schenk M; Hein DW; Davis S; Zahm SH; Cozen W; Cerhan JR; Hartge P; Welch R; Chanock SJ; Rothman N; Wang SS
    Pharmacogenet Genomics; 2006 Aug; 16(8):537-45. PubMed ID: 16847422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential interactions between GSTM1 and NAT2 genotypes on aromatic DNA adduct level and HPRT mutant frequency in lung cancer patients and population controls.
    Hou SM; Fält S; Yang K; Nyberg F; Pershagen G; Hemminki K; Lambert B
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):133-40. PubMed ID: 11219770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association analyses between polymorphisms of the phase II detoxification enzymes (GSTM1, NQO1, NQO2) and alcohol withdrawal symptoms.
    Okubo T; Harada S; Higuchi S; Matsushita S
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):68S-71S. PubMed ID: 12960511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic polymorphisms of phase II metabolic enzymes and lung cancer susceptibility in a population of Central South China.
    Chen HC; Cao YF; Hu WX; Liu XF; Liu QX; Zhang J; Liu J
    Dis Markers; 2006; 22(3):141-52. PubMed ID: 16788248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.